Clinical Trials on Melanoma (Skin)

Total 51958 results

National Cancer Institute (NCI)

Terminated

Ipilimumab With or Without Dabrafenib, Trametinib, and/or Nivolumab in Treating Patients With Melanoma That Is Metastatic or Cannot Be Removed by Surgery

Metastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | BRAF V600E Mutation Present | BRAF V600K Mutation Present | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...
Pfizer

Active, not recruiting

Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma

Ciliary Body and Choroid Melanoma, Medium/Large Size | Ciliary Body and Choroid Melanoma, Small Size | Iris Melanoma | Stage IIIA Intraocular Melanoma | Stage IIIB Intraocular Melanoma | Stage IIIC Intraocular Melanoma | Stage I Intraocular Melanoma | Stage IIA Intraocular Melanoma | Stage IIB Intraocular... and other conditions

United States
NCIC Clinical Trials Group
National Cancer Institute (NCI)

Completed

Perifosine in Treating Patients With Metastatic or Recurrent Malignant Melanoma

Melanoma (Skin)

Canada
NCIC Clinical Trials Group
ZymoGenetics

Completed

Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma

Melanoma (Skin)

Canada
University Hospital, Strasbourg, France
Bristol-Myers Squibb

Completed

Cryotherapy With in Situ Immunotherapy in Melanoma Metastasis (CRIRIN)

Melanoma (Skin)

France
Jonsson Comprehensive Cancer Center
National Institutes of Health (NIH)

Completed

Vaccine Therapy in Treating Patients With Stage IV or Recurrent Malignant Melanoma

Melanoma (Skin)

United States
University of Maryland, Baltimore
National Cancer Institute (NCI)

Terminated

0794GCC: Pentamidine in Treating Patients With Relapsed or Refractory Melanoma

Melanoma (Skin)

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Carboplatin and ABI-007 in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

Melanoma (Skin)

United States
Southwest Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group

Completed

S9431: Studying Genes and Immune Response in Tumor Samples From Patients With Locally Advanced or Metastatic Melanoma

Melanoma (Skin)
Pawel Kalinski
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Melanoma (Skin)

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

Cyclophosphamide and Fludarabine Followed By Interleukin-2 Gene-Modified Tumor Infiltrating Lymphocytes in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma

Melanoma (Skin)

United States
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Completed

Biomarkers to Predict Response to Interferon Therapy in Patients With Melanoma

Melanoma (Skin)
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Completed

Biomarkers in Predicting Response to Chemotherapy in Patients With Advanced or Metastatic Melanoma Previously Treated With Carboplatin and Paclitaxel With or Without Sorafenib Tosylate

Melanoma (Skin)
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Completed

Study of Tumor Tissue From Patients With Melanoma Treated on Clinical Trial EST-1690

Melanoma (Skin)
Stanford University
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaborators

Completed

Pilot Trial to Evaluate the Effect of Vitamin D on Melanocyte Biomarkers

Melanoma, Skin

United States
Mayo Clinic
National Cancer Institute (NCI)

Terminated

Paclitaxel and Carboplatin or Temozolomide in Treating Patients With Stage IV Melanoma

Melanoma (Skin)

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

CCI-779 in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States, Canada
University Hospital Erlangen

Completed

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Melanoma (Skin)

Germany
National Cancer Institute (NCI)

Completed

Interleukin-7 and Vaccine Therapy in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
Duke University
National Cancer Institute (NCI)

Completed

Sorafenib and Isolated Limb Infusion of Melphalan in Treating Patients With Stage III Melanoma of the Arm or Leg

Melanoma (Skin)

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Melanoma (Skin)

United States
Aurora Health Care

Terminated

Laboratory-Treated Autologous Lymphocytes and Aldesleukin After Cyclophosphamide and Fludarabine in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
Craig L Slingluff, Jr
National Cancer Institute (NCI)

Completed

Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma

Melanoma (Skin)

United States
Mount Vernon Cancer Centre at Mount Vernon Hospital

Unknown

Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma

Melanoma (Skin)

United Kingdom
Dermatologische Klinik MIT Poliklinik-Universitaetsklinikum...

Unknown

Vaccine Therapy in Treating Patients With Stage IV Melanoma

Melanoma (Skin)

Germany
Beth Israel Deaconess Medical Center

Unknown

Boron Neutron Capture Therapy in Treating Patients With Stage III Melanoma

Melanoma (Skin)

United States
University of Illinois at Chicago
National Cancer Institute (NCI)

Completed

Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
Beth Israel Deaconess Medical Center

Completed

Boron Neutron Capture Therapy in Treating Patients With Melanoma

Melanoma (Skin)

United States
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma

Melanoma (Skin)

United States
National Cancer Institute (NCI)

Completed

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Recurrent or Refractory Metastatic Melanoma

Melanoma (Skin)

United States
National Cancer Institute (NCI)

Completed

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Melanoma (Skin)

United States
National Cancer Institute (NCI)

Completed

Lymphocyte-Depleting Nonmyeloablative Preparative Chemotherapy Followed By Autologous Lymphocyte Infusion, Peptide Vaccine Plus Montanide ISA-51, and Interleukin-2 in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
National Cancer Institute (NCI)

Completed

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma That Has Not Responded to Previous Treatment

Melanoma (Skin)

United States
National Cancer Institute (NCI)

Completed

Dacarbazine and/or Cisplatin Compared With Complete Metastasectomy in Treating Patients With Stage IV Melanoma

Melanoma (Skin)

United States
Iceland Genomics Corporation
National Cancer Institute (NCI)

Completed

Studying Genes to Identify Melanoma in Patients in Iceland and Their Family Members

Melanoma (Skin)

Iceland
Bristol-Myers Squibb
National Cancer Institute (NCI)

Withdrawn

Ipilimumab With or Without Vaccine Therapy in Treating Patients With Previously Treated Stage IV Melanoma

Melanoma (Skin)
University of Alabama at Birmingham
National Cancer Institute (NCI)

Completed

Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma

Melanoma (Skin)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

PET and CT Scans to Evaluate Patients With Stage III or Stage IV Melanoma

Melanoma (Skin)

United States
European Organisation for Research and Treatment...

Terminated

Boron Neutron Capture Therapy Using Boronophenylalanine-Fructose Complex in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

Germany
European Organisation for Research and Treatment...

Unknown

High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma

Melanoma (Skin)

France, Switzerland, Netherlands, Poland, Finland, Belgium, United Kingdom, Austria, Germany, Italy, Israel, Slovakia, Spain, Serbia, Portugal, Russian Federation, Bulgaria, Croatia, Turkey, Estonia, Sweden
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma

Melanoma (Skin)

France
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Biological Therapy in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
University of Minnesota
American Cancer Society, Inc.; Melanoma Research Alliance

Completed

Wearable Device Intervention to Improve Sun Behaviors in Melanoma Survivors

Melanoma (Skin)

United States
National Cancer Institute (NCI)

Terminated

Anti-gp100 Cells Plus ALVAC gp100 Vaccine to Treat Advanced Melanoma

Skin Cancer | Metastatic Melanoma

United States
Universiti Tunku Abdul Rahman

Completed

OneDoc Picopulse™ for the Treatment of Melasma Among Malaysian Women

Skin Diseases | Melanoma (Skin) | Skin Disorder

Malaysia
Novartis Pharmaceuticals

Recruiting

A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas

Metastatic Uveal Melanoma

United States, Australia, France, Netherlands, Switzerland, Germany, Spain

Clinical Trials on Melanoma (Skin)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations